Skip to content

Shunti bilwa kashaya and tab doxinate effect in Garbhini Chardi

A Randomised Controlled Trial To Evaluate The Efficacy Of Shunthi-Bilwa Kashaya In Garbhini Chardi W.S.R.To Emesis Gravidarum. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096180
Enrollment
80
Registered
2025-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Sponsors

Dr Yogita Kamlesh Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Pregnant females diagnosed as garbhini chardi in first trimester of pregnancy of any gravida 2 ANC profile already done by patient

Exclusion criteria

Exclusion criteria: 1 Hyperemesis Gravidarum 2 Pregnant woman suffering from severe infections such as TORCH etc 3 Pregnant woman suffering from systemic disorders such as DM HTN THYROID etc 4 Pregnant woman on other medications such as Antibiotics Antifungal etc

Design outcomes

Primary

MeasureTime frame
To Evaluate and Compare the Efficacy of Shunthi-Bilwa Kashaya and Tablet Doxinate in Garbhini Chardi w.s.r.t. Emesis Gravidarum.Timepoint: 1st Visit - Baseline 2nd Visit - 3rd day 3rd Visit - 7th day 4th Visit 15th day

Secondary

MeasureTime frame
To Study the Complete Literature on Garbhini Chardi & Emesis Gravidarum available in Texts. Timepoint: 1st Visit - Baseline 2nd Visit - 3rd day 3rd Visit - 7th day 4th Visit 15th day

Countries

India

Contacts

Public ContactDR YOGITA KAMLESH YADAV

Dr G D pol Foundation YMT Ayurvedic Medical College and Hospital

dr.jenybhatt@gmail.com9167541086

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026